FMC, Arysta LifeScience enter agreement with Xonerate, Disarm
FMC Corporation and Arysta LifeScience North America, LLC announced the signing of an exclusive licensing agreement in which FMC will develop and market two key turf and ornamental products, Disarm Fungicide (fluoxastrobin) and Xonerate Herbicide (amicarbazone), in the U.S. and Canada, from Arysta LifeScience. The agreement became effective Aug 12. “This exclusive agreement unites two complementary product lines, expanding FMC Professional Solutions... read more